INFORMATION FOR
News
Yale Cancer Center researchers at Yale School of Medicine will present new research at the 46th annual San Antonio Breast Cancer Symposium (SABCS) from December 5 to 9.
A research team co-led by Dr. Katerina Politi found how mSWI/SNF complexes mediate resistance of lung adenocarcinomas to osimertinib and other tyrosine kinase inhibitors.
A new study from Yale Cancer Center scientists has identified the chromatin regulator WDR5 as a possible new drug target in triple negative breast cancer.
The American Society for Investigative Pathology has announced it will honor Qin Yan, PhD, Associate Professor of Pathology at Yale School of Medicine, with its 2023 Outstanding Investigator Award.
Three Yale Pathology faculty members were recently honored for their contributions to cancer research and education during the Yale Cancer Center Annual Conclave on February 15, 2022.
New Haven’s biotech community has seen fits and starts, but today it is achieving critical mass. Upwards of 50 biotech and medical device companies employ more than 5,000 people in greater New Haven. Yale School of Medicine has been instrumental in the communty's growth.
To better understand how cancer initiates and spreads, Yale associate professor of pathology Qin Yan turned to the field of epigenetics.
Yale cancer biologist Dr. Qin Yan has been awarded $4.1 million from the U.S. Department of Defense (DoD) for a project that will explore finding new drug targets and more effective treatments for metastatic breast cancer.
A team at Yale Cancer Center led by Qin Yan, PhD, Associate Professor of Pathology, has discovered a regulating enzyme called RBP2 that breast cancer cells need in order to metastasize to the lung.
Yale Cancer Center researchers have identified a regulator of gene expression that is responsible for the progression of breast cancer and its metastasis to the lung. The study appears online in Cell Reports.
Yale School of Public Health researchers evaluate the association between exposure to hot temperatures during pregnancy and the risk of cancer in children.
A recent study conducted by scientists at Yale Cancer Center demonstrates that spatial gene signatures can significantly enhance the prediction of immunotherapy outcomes in patients with melanoma.
Profiles in Survivorship: Craig Studer
Dr. Vasilis Vasiliou on Yale Cancer Answers.
Learn three main areas of research within Yale Urology and what motivates the faculty behind it.
Stephen, 61, traveled over 5,000 from Hawaii to Yale to have Dr. Jennifer Moliterno perform brain surgery. Dr. Moliterno performs more brain surgeries than any other physician in Connecticut, and patients like Stephen travel long distances due to her experience and efficiency.
In an interview, Rachel Perry, PhD, discusses the link between insulin and cancer, a surprising finding in her research, and the future of precision medicine for metabolism-related cancers.
Amos S. Espinosa, a PhD Candidate in Experimental Pathology, was recently named a winner of the American Society of Hematology's Minority Hematology Graduate Award.
Melinda, 67, approached her brain tumor with the same singular focus she approaches everything in life - and with the help of a World-Class Yale surgeon.
Learn about Yale Urology's new tradition and how it serves as seed money, encouraging faculty to take calculated risks and try new approaches that may lead to innovative patient care solutions.